These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34807749)

  • 1. Mesenchymal Stem/Stromal Cells Overexpressing CXCR4
    Bidkhori HR; Bahrami AR; Farshchian M; Heirani-Tabasi A; Mirahmadi M; Hasanzadeh H; Ahmadiankia N; Faridhosseini R; Dastpak M; Shabgah AG; Matin MM
    Cell Transplant; 2021; 30():9636897211054498. PubMed ID: 34807749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome.
    Kawai T; Choi U; Whiting-Theobald NL; Linton GF; Brenner S; Sechler JM; Murphy PM; Malech HL
    Exp Hematol; 2005 Apr; 33(4):460-8. PubMed ID: 15781337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The negative charge of the 343 site is essential for maintaining physiological functions of CXCR4.
    Wang L; Xiong Q; Li P; Chen G; Tariq N; Wu C
    BMC Mol Cell Biol; 2021 Jan; 22(1):8. PubMed ID: 33485325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of the chemokine receptor CXCR4.
    Luo J; De Pascali F; Richmond GW; Khojah AM; Benovic JL
    J Biol Chem; 2022 Feb; 298(2):101551. PubMed ID: 34973340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4.
    Kawai T; Choi U; Cardwell L; DeRavin SS; Naumann N; Whiting-Theobald NL; Linton GF; Moon J; Murphy PM; Malech HL
    Blood; 2007 Jan; 109(1):78-84. PubMed ID: 16946301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptors.
    Gómez-Moutón C; Fischer T; Peregil RM; Jiménez-Baranda S; Stossel TP; Nakamura F; Mañes S
    Blood; 2015 Feb; 125(7):1116-25. PubMed ID: 25355818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation.
    Bhakta S; Hong P; Koc O
    Cardiovasc Revasc Med; 2006; 7(1):19-24. PubMed ID: 16513519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies.
    Dotta L; Notarangelo LD; Moratto D; Kumar R; Porta F; Soresina A; Lougaris V; Plebani A; Smith CIE; Norlin AC; Gòmez Raccio AC; Bubanska E; Bertolini P; Amendola G; Visentini M; Fiorilli M; Venuti A; Badolato R
    J Allergy Clin Immunol Pract; 2019; 7(5):1568-1577. PubMed ID: 30716504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMD3100 is a potent antagonist at CXCR4(R334X) , a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome.
    McDermott DH; Lopez J; Deng F; Liu Q; Ojode T; Chen H; Ulrick J; Kwatemaa N; Kelly C; Anaya-O'Brien S; Garofalo M; Marquesen M; Hilligoss D; DeCastro R; Malech HL; Murphy PM
    J Cell Mol Med; 2011 Oct; 15(10):2071-81. PubMed ID: 21070597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients.
    García-Cuesta EM; Rodríguez-Frade JM; Gardeta SR; D'Agostino G; Martínez P; Soler Palacios B; Cascio G; Wolf T; Mateos N; Ayala-Bueno R; Santiago CA; Lucas P; Llorente L; Allende LM; González-Granado LI; Martín-Cófreces N; Roda-Navarro P; Sallusto F; Sánchez-Madrid F; García-Parajo MF; Martínez-Muñoz L; Mellado M
    Proc Natl Acad Sci U S A; 2022 May; 119(21):e2119483119. PubMed ID: 35588454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.
    Liu Q; Chen H; Ojode T; Gao X; Anaya-O'Brien S; Turner NA; Ulrick J; DeCastro R; Kelly C; Cardones AR; Gold SH; Hwang EI; Wechsler DS; Malech HL; Murphy PM; McDermott DH
    Blood; 2012 Jul; 120(1):181-9. PubMed ID: 22596258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebellar involvement in warts Hypogammaglobulinemia immunodeficiency myelokathexis patients: neuroimaging and clinical findings.
    Galli J; Pinelli L; Micheletti S; Palumbo G; Notarangelo LD; Lougaris V; Dotta L; Fazzi E; Badolato R
    Orphanet J Rare Dis; 2019 Feb; 14(1):61. PubMed ID: 30819232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL12/CXCR4-axis dysfunctions: Markers of the rare immunodeficiency disorder WHIM syndrome.
    Bachelerie F
    Dis Markers; 2010; 29(3-4):189-98. PubMed ID: 21178277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome.
    Dotta L; Tassone L; Badolato R
    Curr Mol Med; 2011 Jun; 11(4):317-25. PubMed ID: 21506920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse.
    Kallikourdis M; Trovato AE; Anselmi F; Sarukhan A; Roselli G; Tassone L; Badolato R; Viola A
    Blood; 2013 Aug; 122(5):666-73. PubMed ID: 23794067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced anti-inflammatory effects of mesenchymal stromal cells mediated by the transient ectopic expression of CXCR4 and IL10.
    Hervás-Salcedo R; Fernández-García M; Hernando-Rodríguez M; Quintana-Bustamante O; Segovia JC; Alvarez-Silva M; García-Arranz M; Minguez P; Del Pozo V; de Alba MR; García-Olmo D; Ayuso C; Lamana ML; Bueren JA; Yañez RM
    Stem Cell Res Ther; 2021 Feb; 12(1):124. PubMed ID: 33579367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4
    Zmajkovicova K; Pawar S; Maier-Munsa S; Maierhofer B; Wiest I; Skerlj R; Taveras AG; Badarau A
    Genes Immun; 2022 Sep; 23(6):196-204. PubMed ID: 36089616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4 signaling controls dendritic cell location and activation at steady state and in inflammation.
    Gallego C; Vétillard M; Calmette J; Roriz M; Marin-Esteban V; Evrard M; Aknin ML; Pionnier N; Lefrançois M; Mercier-Nomé F; Bertrand Y; Suarez F; Donadieu J; Ng LG; Balabanian K; Bachelerie F; Schlecht-Louf G
    Blood; 2021 May; 137(20):2770-2784. PubMed ID: 33512478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding CXCR4 variant landscape in WHIM syndrome: integrating clinical and functional data for variant interpretation.
    Zmajkovicova K; Nykamp K; Blair G; Yilmaz M; Walter JE
    Front Immunol; 2024; 15():1411141. PubMed ID: 39040098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling.
    Balabanian K; Levoye A; Klemm L; Lagane B; Hermine O; Harriague J; Baleux F; Arenzana-Seisdedos F; Bachelerie F
    J Clin Invest; 2008 Mar; 118(3):1074-84. PubMed ID: 18274673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.